Robert James Rudelius Insider Trading $LECT Axogen, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert James Rudelius.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert James Rudelius. Robert James Rudelius is Director in AxoGen, Inc. ($LECT) and Director in ProUroCare Medical Inc. ($PUMD) and Director in PetVivo Holdings, Inc. ($PETV).

Robert James Rudelius in Axogen, Inc.

Trading Symbol: LECT
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of Robert James Rudelius: Director
Holdings: 48,183 shares
Latest Transaction: Sep 08 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Robert James Rudelius in Axogen, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, LECT, PETV, PUMD

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 08 2020LECTAxogen, Inc.Rudelius Robert JamesDirectorGrantA11.752,59130,44448,18345.6 K to 48.2 K (+5.68 %)
Jan 03 2020LECTAxogen, Inc.Rudelius Robert JamesDirectorOption ExerciseM2.7513,00035,7500
Jan 03 2020LECTAxogen, Inc.Rudelius Robert JamesDirectorPayment of ExerciseF17.891,99935,76245,59247.6 K to 45.6 K (-4.20 %)
Jan 03 2020LECTAxogen, Inc.Rudelius Robert JamesDirectorBuyM2.7513,00035,75047,59134.6 K to 47.6 K (+37.58 %)
Sep 04 2019LECTAxogen, Inc.Rudelius Robert JamesDirectorOption ExerciseA0.002,59102,591
Sep 04 2019LECTAxogen, Inc.Rudelius Robert JamesDirectorOption ExerciseA15.4410,710165,36210,710
Jun 12 2018LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseM2.7512,00033,0000
Jun 12 2018LECTAxoGen, Inc.Rudelius Robert JamesDirectorPayment of ExerciseF48.4068233,00934,59135.3 K to 34.6 K (-1.93 %)
Jun 12 2018LECTAxoGen, Inc.Rudelius Robert JamesDirectorBuyM2.7512,00033,00035,27323.3 K to 35.3 K (+51.56 %)
Jun 05 2018LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseA49.654,780237,3274,780
Sep 12 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseM3.5020,00070,0000
Sep 12 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorSellS18.0016,143290,57423,27339.4 K to 23.3 K (-40.96 %)
Sep 12 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorPayment of ExerciseF18.153,85770,00539,41643.3 K to 39.4 K (-8.91 %)
Sep 12 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorBuyM3.5020,00070,00043,27323.3 K to 43.3 K (+85.94 %)
Jun 05 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseA14.8515,000222,75015,000
Jan 03 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseA8.955,00044,7505,000
Jan 03 2017LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseA8.955,00044,7505,000
Dec 30 2015LECTAxoGen, Inc.Rudelius Robert JamesDirectorOption ExerciseA5.0915,00076,35015,000

Page:   1